Physician profile
Jacquelyn Ross
NPI 1376003137
$2,502.02
in general payments reported to CMS, 2019-2025
15 companies · $954 in 2025
The $954 reported for 2025 was more than what 87% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $229 · 2022: $390 · 2023: $381 · 2024: $549 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,883.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $468.97 | 2023-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $394.22 | 2022-2025 | Lifevest |
| Medtronic, INC. | $318.68 | 2025 | Corevalve Evolut R |
| Abiomed | $176.74 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $170.40 | 2022-2024 | Xarelto |
| Amgen INC. | $170.13 | 2023-2025 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $153.12 | 2021-2023 | Farxiga |
| Pfizer INC. | $141.03 | 2021-2025 | |
| Edwards Lifesciences Corporation | $138.46 | 2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $138.09 | 2025 | Mitraclip |
| Regeneron Healthcare Solutions, INC. | $105.06 | 2021 | |
| Atricure, INC. | $52.82 | 2025 | Synergy Ablation System |
| Kestra Medical Technology Services, INC. | $36.74 | 2023-2024 | Assure Wcd |
| W. L. Gore & Associates, INC. | $22.81 | 2022 | |
| Merck Sharp & Dohme LLC | $14.75 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.